ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1020

Risk Factors Can Classify Individuals Who Develop Accelerated Knee Osteoarthritis

Jeffrey Driban1, Timothy E. McAlindon2, Mamta Amin3, Lori Lyn Price4, Charles B. Eaton5, Julie Davis6, Bing Lu7, Grace H. Lo8, Jeffrey Duryea9 and Mary Barbe10, 1Tufts Medical Center, Boston, MA, 2Division of Rheumatology, Tufts Medical Center, Boston, MA, 3Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA, 4Clinical Care Research, Tufts Medical Center, Boston, MA, 5Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 6Rheumatology, Tufts Medical Center, Boston, MA, 7Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 8Immunology, Allergy, Rheumatology, Baylor College of Medicine, Houston, TX, 9Radiology, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA, 10Temple University School of Medicine, Philadelphia, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Knee, osteoarthritis and phenotypes

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoarthritis – Clinical Aspects I: Epidemiology and Progression

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Accelerated knee osteoarthritis (KOA) is a painful disorder and associated with several risk factors: greater age, greater body mass index (BMI), static knee alignment, and coronal tibial slope. While no single risk factor can accurately predict who is at risk for accelerated KOA, it would be beneficial to recognize the combinations of risk factors that identify people at risk for accelerated KOA. Hence, we assessed which combinations of risk factors can classify adults who develop accelerated KOA or not and which risk factors are most important.

Methods: We conducted a case-control study using data from baseline and the first 4 annual visits of the Osteoarthritis Initiative. Eligible participants had no radiographic KOA at baseline (Kellgren-Lawrence [KL] < 2). We classified 3 groups: 1) accelerated KOA: ≥ 1 knee progressed to advance-stage KOA (KL 3 or 4) within 48 months, 2) typical onset of KOA: ≥ 1 knee increased in radiographic scoring within 48 months (excluding those defined as accelerated KOA), and 3) No KOA: no change in KL grade by 48-months. We did 1:1:1 matching for the 3 groups based on sex. A laboratory blinded to group assignment conducted serum assays in duplicate for CRP, GSP, and glucose concentrations. Staff recorded age, sex, and BMI based on standardized protocols. Weight-bearing, fixed flexion posterior-anterior knee radiographs were obtained at baseline and follow-up visits.  One reader manually measured baseline coronal tibial slope (ICC = 0.87). Baseline femorotibial alignment angle was measured on the radiographs using a semi-automated program software tool. We performed classification and regression tree (CART) analysis to determine rules for classifying individuals as accelerated KOA or not (no KOA and gradual onset) based on baseline age, BMI, coronal tibial slope, static alignment, serum measures, and sex.

Results: Based on the CART analysis, the most important baseline variables for classifying individuals with incident accelerated KOA (in order of importance) were BMI, glucose concentrations, and age (Figure 1). Individuals < 63.5 years of age were likely not to develop accelerated KOA, except when they were overweight. Individuals ≥ 63.5 years of age were more likely to develop accelerated KOA unless their glucose levels were > 81.98 mg/dL, had varus malalignment, and had GSP concentrations < 225.6 nMol/mL. The relative error (unexplained variance) of the CART = 63%.

Conclusion: Age, BMI, and serum assays may enable the classification of individuals who will develop accelerated KOA in the subsequent 4 years. Future studies should explore other novel risk factors that may help classify individuals at risk for accelerated KOA and recognize the complex inter-play between risk factors. Figure 1. Classification and Regression Tree for Accelerated Knee Osteoarthritis (AKOA) versus those without AKOA

 


Disclosure: J. Driban, None; T. E. McAlindon, None; M. Amin, None; L. L. Price, None; C. B. Eaton, None; J. Davis, None; B. Lu, None; G. H. Lo, None; J. Duryea, None; M. Barbe, None.

To cite this abstract in AMA style:

Driban J, McAlindon TE, Amin M, Price LL, Eaton CB, Davis J, Lu B, Lo GH, Duryea J, Barbe M. Risk Factors Can Classify Individuals Who Develop Accelerated Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/risk-factors-can-classify-individuals-who-develop-accelerated-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-can-classify-individuals-who-develop-accelerated-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology